BMO Capital raised the firm’s price target on Ameren (AEE) to $98 from $93 and keeps an Outperform rating on the shares. The firm cites the company having filed testimony in the Missouri rate case, with the headline proposed revenue increase of $398M that compares favorably to the company’s $446M request, the analyst tells investors in a research note. The initial testimony and rate of return parameters from Staff are a “constructive starting point”, BMO added.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AEE:
- Ameren CFO Moehn sells 6,500 common shares
- Ameren price target lowered to $86 from $88 at Morgan Stanley
- Ameren Corporation Reports Steady Earnings Amid Strategic Investments
- Ameren reports Q3 adjusted EPS $1.87, consensus $1.91
- Ameren sees FY24 EPS $4.55-$4.69, consensus $4.62
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
